PW–035Clinical Trial
Immune Support
LL-37
Defence against microbes and immune cell activity
Main contextProtection against microbes
Goals
Immune Support
2 peptides2 protocols
Peptides commonly researched for immune support applications.
Research Use Only: This information is for educational and research purposes only. Not intended for medical advice or self-medication.
Recommended Peptides
Peptides commonly researched for immune support applications.
Peptide Comparison
Compare key properties of immune support peptides side by side.
Immune Support Peptides
Compare 2 peptides commonly studied for immune support applications
| Typical Dose | |||||
|---|---|---|---|---|---|
| LL-37 | Clinical Trial | 🛡️Immune Support | 4,493.33 Da | 150 mcg Daily, 5 days per week, 2-4 week cycles | |
| Thymosin Alpha-1 | Approved | 🛡️Immune Support | 3,108.27 Da | 1.6 mg 2-3 times weekly for immune support; daily for 7-14 days for acute |
Comparing 2 peptides
Related Protocols
Research protocols targeting immune support objectives.
LL-37 Antimicrobial Protocol
🛡️Immune SupportIntermediate
Natural antimicrobial peptide for immune support, wound healing, and gut repair.
Duration:10 weeks total (with 2-week washout)
Frequency:Daily for weeks 1-4, washout weeks 5-6, repeat weeks 7-10
1 peptide
LL-37
Thymosin Alpha-1 Immune Protocol
🛡️Immune SupportIntermediate
Immune modulating peptide for chronic illness, immune deficiency, and infection recovery.
Duration:Minimum 3 months
Frequency:2-3 times weekly
1 peptide
Thymosin Alpha-1
Need Help with Dosages?
Use our dosage calculator to determine reconstitution volumes, injection amounts, and how many doses you can get from each vial for any peptide.